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Abstract
Aim. There is limited evidence of the safety and impact of task-shared care for people with
severe mental illnesses (SMI; psychotic disorders and bipolar disorder) in low-income coun-
tries. The aim of this study was to evaluate the safety and impact of a district-level plan for
task-shared mental health care on 6 and 12-month clinical and social outcomes of people
with SMI in rural southern Ethiopia.
Methods. In the Programme for Improving Mental health carE, we conducted an intervention
cohort study. Trained primary healthcare (PHC) workers assessed community referrals, diag-
nosed SMI and initiated treatment, with independent research diagnostic assessments by psy-
chiatric nurses. Primary outcomes were symptom severity and disability. Secondary outcomes
included discrimination and restraint.
Results. Almost all (94.5%) PHC worker diagnoses of SMI were verified by psychiatric nurses.
All prescribing was within recommended dose limits. A total of 245 (81.7%) people with SMI
were re-assessed at 12 months. Minimally adequate treatment was received by 29.8%. All clin-
ical and social outcomes improved significantly. The impact on disability (standardised mean
difference 0.50; 95% confidence interval (CI) 0.35–0.65) was greater than impact on symptom
severity (standardised mean difference 0.28; 95% CI 0.13–0.44). Being restrained in the pre-
vious 12 months reduced from 25.3 to 10.6%, and discrimination scores reduced significantly.
Conclusions. An integrated district level mental health care plan employing task-sharing
safely addressed the large treatment gap for people with SMI in a rural, low-income country
setting. Randomised controlled trials of differing models of task-shared care for people with
SMI are warranted.
Introduction
The treatment gap for people with severe mental illness (SMI) is over 90% in most low-income
countries (Wang et al., 2007). A ‘full’ task-sharing model whereby primary healthcare (PHC)
workers are equipped to deliver all aspects of first-line mental health care, with limited special-
ist support, is recommended to increase access to care. Full task-sharing is at the heart of the
World Health Organisation (WHO)’s mental health Gap Action Programme (mhGAP)
(World Health Organization, 2008). However, many studies of task-shared care for SMI
have employed a model whereby a mental health specialist makes the diagnosis of SMI, initi-
ates treatment and provides an ongoing review, combined with the involvement of non-
specialists in delivering psychosocial aspects of care (Chatterjee et al., 2014). This ‘partial’
model of task-sharing cannot address the needs of most people with SMI in low-income coun-
tries due to the scarcity of mental health professionals. In the few examples of programmes
employing a ‘full’ task-sharing approach (Ventevogel et al., 2012; Gureje et al., 2015), there
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is only limited evidence on whether care can be delivered safely and
with sufficient quality to bring about improved outcomes for people
with SMD (Jordans et al., 2017; Jordans et al., 2019). This lack of evi-
dence may be fuelling reluctance to embrace the more ambitious
task-sharing approach (Hanlon et al., 2016b). To address this evi-
dence gap, we present findings from the Programme for Improving
Mental health carE (PRIME) (Fekadu et al., 2016). We have shown
that PRIME in Ethiopia achieved contact coverage of over 80% for
peoplewith SMI in the target population. The objective of the current
study was to investigate the impact of implementing a district level
mental health care planon the 12-month clinical and social outcomes
of people with SMI who engaged with primary mental health care in
Ethiopia.
Methods
Study design
We conducted an intervention cohort study, with assessments
conducted at the baseline of implementation of the district mental
health care plan (T0), and 6 (T1) and 12 months (T2) after initial
engagement of people with SMI in the new integrated service.
Setting
ThePRIMEstudywas carried out in Sododistrict, in theGurage Zone
of the Southern Nations, Nationalities and Peoples’ Region of south-
ernEthiopia fromDecember 2014 to July 2016. Sodohas an estimated
population of around160 000people (Hanlon et al., 2014).More than
90% of inhabitants live in rural areas and rely on subsistence farming
and small-scale trading. At the time of the study, health services in
Sodo comprised 54 health posts, most of which were staffed by two
community health extension workers with 1 year of training in gen-
eral health promotion and illness prevention, and eight health centres,
staffed by nurses, health officers and midwives, who provide basic
curative and obstetric care. There were no doctors or mental health
specialists in the district. In the nearest town of Butajira, located
30–50 km from Sodo, there was a psychiatric nurse-led out-patient
clinic. The nearest in-patient mental health services were 100–
120 km away in the capital city, Addis Ababa.
Sample and recruitment procedures
As described previously (Baron et al., 2018), people with possible
SMI in the community were identified by community key infor-
mants and health extension workers who had received half a
day of training in typical presentations of SMI (Shibre et al.,
2002). People with possible SMI were referred to the nearest
health centre and assessed by PHC workers who had been trained
in mental health care for a total of 10 days: 5 days of classroom-
based teaching using adapted mhGAP training materials and 5
days of practical clinical training in the Butajira psychiatric clinic.
The PHC workers assessed the referrals, made a diagnosis of SMI
and initiated treatment according to the evidence-based clinical
guidelines in the WHO mhGAP Intervention Guide (World
Health Organization, 2016). Independent diagnostic review was
carried out with standardised, semi-structured clinical assess-
ments by research psychiatric nurses using the OPerational
CRITeria for research (OPCRIT) (McGuffin et al., 1991).
Diagnostic assessments were conducted for all people with PHC
worker-diagnosed SMI and wherever the PHC worker was uncer-
tain about the diagnosis. The research psychiatric nurses reviewed
the initial treatment plan. Any changes made by the psychiatric
nurses were communicated back to the PHC workers.
Eligibility criteria
• Confirmatory research psychiatric nurse diagnosis of a psych-
otic disorder (including schizophrenia, schizoaffective disorder
and depression with psychotic features) or bipolar disorder.
• Providing informed consent, or caregiver permission, to partici-
pate in the study if the person with SMI lacked capacity to
consent.
• Able to converse in Amharic, the official language of the region.
• Planning to reside in the district for at least 12 months.
• No cognitive or sensory impairment that interfered substan-
tially with the clinical assessment.
• Not acutely physically unwell.
Sample size
The sample size for the PRIME SMI cohorts across countries was
calculated to detect a 20% reduction in the severity of symptoms
at 12 months, with 90% power, two-sided alpha of 0.05 and 20%
attrition rate (Baron et al., 2018), leading to a target sample size of
150. However, in the Ethiopia district, all people who received a
confirmatory diagnosis of SMI were included to establish a com-
pletely ascertained population cohort.
PRIME intervention for people with SMI
The integrated district mental health care plan for the Ethiopian
setting has been described in detail previously (Fekadu et al.,
2016), and involved interventions at the level of the health system,
PHC facility and community.
Health system interventions
The district health office staff were involved in participatory plan-
ning using Theory of Change methodology (Hailemariam et al.,
2015). The district health office assigned a focal person for mental
health co-ordination. PRIME provided ongoing technical support
with medication supply management (including establishing a
revolving drug fund and providing assistance with forecasting
the amount of psychotropic medication required), building cap-
acity in supervision of mental healthcare (training high-
performing general health workers to supervise mental health
care) and monitoring and evaluation activities (e.g. aggregating
data on facility contacts and feeding back at the advisory board
meetings).
PHC facility interventions
All frontline PHC workers in Sodo district (n = 128) were trained
in mental healthcare. The PHC workers received monthly super-
vision from a psychiatric nurse trained using the mhGAP super-
visor training manual. For rural health centres, supervision was
conducted by telephone when weather conditions precluded travel
to the facility. PHC workers could also consult the psychiatric
nurse for advice. People with confirmed SMI were prescribed an
antipsychotic and/or antidepressant medication and/or a benzodi-
azepine, as indicated. There were no mood-stabiliser medications
available, so people with bipolar disorder received antipsychotic
medication as per usual practice in this setting (Fekadu et al.,
2015). Almost all service users had to pay for medication.
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In addition to the prescription of medication, PHC workers
were trained to provide psychoeducation, activate social supports,
address social stressors, monitor physical health, review response
to treatment and refer to specialist mental health care if needed.
As prescriptions were usually for a maximum of 1 month,
follow-up appointments with the PHC workers were usually
scheduled monthly.
Community-level interventions
A multi-sectoral ‘community advisory board’ was established to
support community awareness-raising and mobilisation, to help
with trouble-shooting during the implementation phase and to
review project activities and outcomes. A total of 96 community-
based health extension workers were trained in case detection,
outreach to re-engage people who dropped out of care, identifica-
tion of medication side effects, community awareness-raising and
supporting social reintegration and recovery of people with SMI.
In half of the sub-districts, people with schizophrenia who had
enduring symptoms or disability after 6 months received adjuvant
community-based rehabilitation, delivered by trained lay workers
(n = 75) or ongoing PRIME care (n = 87), as part of a nested
cluster randomised trial (the RISE trial) (Asher et al., 2016).
Aside from the additional contacts from CBR workers in the
intervention arm (weekly for 2–3 months and 2-weekly for the
subsequent 5–6 months), there were no additional trial-related
contacts.
Measures
Primary outcomes
• Clinical symptom severity was measured using the Brief
Psychiatric Rating Scale, expanded version (BPRS-E)
(Burlingame et al., 2006). The BPRS-E is a 24-item, clinician-
rated scale which has been translated into Amharic and
shown to have robust psychometric properties and sensitivity
to change in Ethiopia (Habtamu et al., 2017).
• Disability was measured using the World Health Organisation
Disability Assessment Schedule (WHODAS), version 2.0,
36-item version (Üstün et al., 2010). The WHODAS has been
validated for use in people with SMI in Ethiopia and is sensitive
to change (Habtamu et al., 2017). The WHODAS was com-
pleted by a combination of responses from the person with
SMI and the caregiver responses to the proxy-WHODAS at
the post-baseline assessments (19.8% of WHODAS scores
from caregivers at midline, 24.1% at endline). We used the poly-
tomous summary score of the WHODAS scaled from 0 to 100.
Secondary outcomes
• Experience of discrimination was measured using the ‘unfair
treatment’ subscale of the discrimination and stigma scale-12
(DISC-12) (Brohan et al., 2013). The original DISC-12 sub-
scale has 21 items. Four items lacked face validity or had a
low frequency of endorsement, but the remaining 17 items
loaded onto a single factor using exploratory factor analysis
and were summed.
• Restraint was measured by self-report of whether the person
had been ‘restrained, chained or confined’ in the preceding 12
months.
• Alcohol use disorder was measured using the lay interviewer-
administered Alcohol Use Disorder Identification Test
(AUDIT) (Babor et al., 2001). This 10-item scale has been
adapted for local drinks in the Ethiopian setting. People scoring
⩾8 are considered to have a probable alcohol use disorder.
• Depression was measured using a locally validated version of
the Patient Health Questionnaire (PHQ-9) (Kroenke and
Spitzer, 2002). In the Ethiopian setting, a cut-off of 5 or more
is indicative of major depressive disorder (Hanlon et al., 2015).
• Suicide attempts in the past 3 months were assessed using the
Mini International Neuropsychiatric Interview (Sheehan et al.,
1997).
Potential effect modifiers
Equity indicators
• Gender and residence (rural v. urban).
• Socio-economic status: a poverty index was constructed which
loaded onto a unidimensional scale using exploratory factor
analysis: roof material made of straw (v. corrugated iron), unim-
proved water source, unimproved sanitation, no electricity, no
separate room for kitchen, no radio or television, no mobile
phone.
• Time to access the nearest health facility, estimated in minutes,
whatever the means of travel. This was dichotomised into
<60 min v. 60 min or longer.
Baseline characteristic
• Diagnosis: clinician-assessed diagnosis using criteria of the
Diagnostic and Statistical Manual of the American Psychiatric
Association, version IV) (American Psychiatric Association,
1994) from OPCRIT (McGuffin et al., 1991).
Process indicators
• Receipt of minimally adequate treatment used the definition
proposed by Wang et al. (Wang et al., 2002): prescription of
medication on at least one occasion combined with at least
four follow-up appointments with a health worker trained in
mental health. We additionally required that psychotropic
medication should be prescribed at therapeutic levels (World
Health Organization, 2016). Data on the number of facility con-
tacts and prescriptions were extracted from the clinical records,
cross-referenced with a facility registration book.
• Receipt of community support (measured at T1 and T2): sup-
port received with returning to work, remembering to take
medication, improving self-care, meeting people and social
engagement. Responses were summed and binarised: 0–2
types of community support v. 3–5 types of community
support.
• Receipt of in-patient care for mental health problems, contact
with specialist mental health or general health facilities and
traditional or religious healers, and type of care received during
primary health care contacts were measured at T1 and T2.
Descriptive baseline characteristics
• Socio-demographic characteristics (age, educational level, mari-
tal status).
• Social support was assessed using the three-item Oslo Social
Support Scale (OSS-3) (Dalgard et al., 2006), which asks
about number of close supports, extent of concern from sup-
ports and amount of practical support received. The OSS-3
total score was categorised as follows: 3–8 ‘poor support’,
9–11 ‘intermediate support’ and 12–14 ‘strong support’.
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• Duration of illness, type of illness onset (acute/sub-acute v.
gradual), psychiatric hospitalisation in the past 12 months,
presence of co-morbid medical condition and receipt of psycho-
tropic medication at baseline were obtained from the OPCRIT
(McGuffin et al., 1991).
Data collection
The lay interviewers were individuals with an educational level of
at least tenth grade who were recruited from the local area and
trained for 12 days on the study questionnaires and protocols,
including observed practice interviews. The trainers had master’s
level qualifications. Degree-level supervisors monitored data qual-
ity in the field. The clinician assessments were conducted by
research psychiatric nurses who were trained for 7 days by senior
Ethiopian psychiatrists. The OPCRIT diagnoses were double-
checked by an Ethiopian psychiatrist by reviewing the OPCRIT
responses and clinical documentation and conducting verification
interviews (n = 2) where needed.
Data management and analysis
Data were double-entered using EpiData (Lauritsen and Bruus,
2003) and analysed using Stata version 13.1 (StataCorp LP,
2016). The data were summarised descriptively, with outcome
data stratified by equity indicators (gender, residence, distance
from the health facility and poverty status). Comparison of the
characteristics of participants remaining in the cohort with
those lost to follow-up at 12 months, as well as by equity indica-
tors, was conducted using Pearson chi-squared for categorical
variables, Student’s t-test for comparing means in normally dis-
tributed variables and Kruskal Wallis equality-of-populations
rank test for non-normal continuous variables.
Mixed effects linear regression with random intercept was used
to model the change in symptom severity, disability and depres-
sive symptoms over time. We tested for improvement in model
fit using likelihood ratio tests after adding random slopes. We
also tested for any significant difference in the mean change
between T0 and T1 or between T1 and T2. Mixed effects ordinal
regression was used to model change in discrimination score over
time. A prevalence ratio was calculated for change from T0 to T2
in probable alcohol use disorder (AUDIT⩾ 8), suicide attempt in
the preceding 3 months or restraint in the preceding 12 months.
For the primary outcomes, we calculated standardised mean
difference (Borenstein et al., 2009) and examined effect modifica-
tion by the equity indicators, diagnosis (primary psychotic dis-
order v. affective disorder), process indicators (receipt of
minimally adequate treatment and community support) and by
the community-based rehabilitation intervention group for the
RISE trial. This was done by adding an interaction term into
the model and testing for improved model fit using a likelihood
ratio test. Multiple linear regression analysis was conducted to
examine the association between baseline duration of illness and
type of illness onset with 12-month outcomes.
Ethical considerations
Ethical approval was obtained from the Institutional Review
Board of the College of Health Sciences, Addis Ababa
University (No. 084/11/Psy). Informed consent was obtained
where possible. If the person lacked capacity and did not refuse,
the accompanying caregiver was invited to give permission on
the person’s behalf.
Results
Of the 294 people diagnosed by PHC workers as having SMI, 279
were confirmed to have SMI, giving a positive predictive value for
PHC worker diagnosis of 94.9%. A further 21 people referred by
PHC workers to psychiatric nurses for diagnostic review were also
found to have SMI, giving a total of 300 participants. See Fig. 1.
Baseline characteristics
See Table 1. At baseline, there was no significant difference in
symptom severity score, disability, discrimination or depressive
symptoms by gender. The proportion with an alcohol use dis-
order (χ2(1) 48.6750; p < 0.001) or who had been restrained
(χ2(1) 5.1154; p = 0.024) was higher in men. Baseline disability
(t = 2.1012; p = 0.04) and restraint (χ2(1) 3.9058; p = 0.048)
were significantly higher in those with low socioeconomic status.
Perceived negative discrimination at baseline was higher in urban
residents (χ2(1) 3.986; p = 0.049) and people of low socio-
economic status (χ2(1) 4.195; p = 0.04).
Cohort follow-up
A total of 247 (82.3%) people were assessed at T1 (mean 7.4
months; S.D. 1.49) and 245 (81.7%) at T2 (mean 12.3 months; S.D.
1.12) (see Fig. 1). There was no evidence of differential loss to
follow-up based on baseline characteristics (online Supplementary
File 1). During the follow-up period, 11 participants died.
Facility-based intervention
After review by psychiatric nurses, the medication initiated by
PHC workers was unchanged or changed within the same medi-
cation class for 184 (67.7%) participants. Psychiatric nurses
increased the dose or added another medication for 46 (16.9%),
stopped or reduced the dose in 15 (5.9%), changed the class of
medication in 15 (5.5%) and stopped a prescription of depot anti-
psychotic medication in 5 (1.8%).
Participants attended a median of two PHC appointments
during the follow-up period (IQR 2–4; minimum 1 and max-
imum 12) (online Supplementary File 2). Minimally adequate
treatment was received by 89 (29.8%) (online Supplementary
File 3). There was no evidence of prescribing above recommended
limits and only one occurrence of antipsychotic polypharmacy.
Admission for in-patient care was very low (1.4% at T1 and
2.0% at T2) and <10% of participants had direct contact with a
mental health specialist. A high proportion reported receiving
psychosocial support and explanation about medication (online
Supplementary File 4).
Community-based interventions
Most people with SMI reported receiving support with medica-
tion adherence and to improve self-care. More than half received
support to get back to work, but less than a quarter were sup-
ported to get involved in social activities and <10% had support
with meeting people. Almost all support was reported to come
from the family. A small proportion reported contact with trad-
itional or religious healers: 13.0% at T1 and 11.6% at T2.
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Impact on clinical and social outcomes
There was a significant improvement in all clinical (symptom
severity score, depressive symptoms, suicide attempts, alcohol
use disorder) and social (functioning, discrimination, restraint)
(Tables 2 and 3). The standardised mean difference for symptom
severity was 0.18 (95% confidence interval (CI)) 0.02–0.34)
between T0 and T1 and 0.28 (95% CI 0.13–0.44) from T0 to
T2. For disability, the standardised mean difference was larger
at both time-points: T0–T1: 0.27 (95% CI 0.13–0.41), T0–T2:
0.50 (95% CI 0.35–0.65). The test for interaction between the
RISE trial intervention group and the main outcomes (symptom
severity and functioning) at 12 months was non-significant.
For symptom severity and functioning, the magnitude of the
change did not differ between T0 and T1 compared to T1 and
T2. The reduction in depressive symptoms was significantly
greater between T0 and T1 than between T1 and T2 (χ2(1)
4.26; p = 0.039); similarly for change in perceived discrimination
(χ2(1) 3.75; p = 0.053).
There was no statistically significant effect modification by the
equity indicators, diagnosis or process indicators for the primary
outcomes. At T1, higher receipt of community support had a
borderline statistical association with a greater reduction in
symptom severity ( p = 0.19) and disability ( p = 0.09) (online
Supplementary Files 5 and 6). There was no association between
duration of illness or type of illness onset and the mean improve-
ment in the primary outcomes.
Discussion
In this community-ascertained intervention cohort of clinician-
confirmed people with SMI, there was a significant improvement
in clinical and social outcomes after implementation of a district
level mental health care plan. PHC workers diagnosed SMI accur-
ately, prescribed psychotropic medication safely and were
reported to have delivered psychoeducation and provided support
to most people with SMI. The findings from this study are
generalisable to similar rural settings of low-income countries.
Although PHC workers prescribed safely (low polypharmacy
and no doses above the recommended therapeutic range), the
psychiatric nurses did consider that it was necessary to change
the initial prescriptions of psychotropic medication in 30.1% of
cases. This reinforces the need for task-shared care to be sup-
ported by input by mental health specialists, either through regu-
lar supervision or through timely review of newly diagnosed cases.
We are only aware of two previous studies, both from Nepal,
where the impact of a ‘full’ task-sharing model on clinical and
Fig. 1. Flow diagram.
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Table 1. Baseline characteristics of the severe mental disorder cohort stratified by gender
Characteristics
Total N (%) Male N (%) Female N (%)
300 (100.0) 172 (57.3) 128 (42.7)
Age (years) Mean (S.D.) 35.5 (13.45) 36.6 (12.86) 34.1 (14.1)
Educational level (n = 299) No formal education 157 (52.5) 79 (46.2) 78 (60.9)
Primary education 112 (37.5) 75 (43.9) 37 (28.9)
Secondary and above 30 (10.0) 17 (9.9) 13 (10.2)
Religious affiliation Orthodox Christian 270 (90.0) 154 (89.5) 116 (90.6)
Muslim 10 (3.3) 7 (4.1) 3 (2.3)
Protestant Christian 19 (6.3) 10 (5.8) 9 (7.0)
None 1 (0.3) 1 (0.6) 0 (0.0)
Ethnicity Gurage 284 (94.7) 162 (94.2) 122 (95.3)
Other 16 (5.3) 10 (5.8) 6 (4.7)
Marital status Married 111 (37.0) 66 (38.4) 45 (35.2)
Single 136 (45.3) 83 (48.3) 53 (41.1)
Divorced or widowed 53 (17.7) 23 (13.4) 30 (23.4)
Household size (n = 298) 1–2 34 (11.4) 19 (11.1) 15 (11.8)
3–4 85 (28.5) 46 (26.9) 39 (30.7)
5–6 92 (30.9) 47 (27.5) 45 (35.4)
7 or more 87 (29.2) 59 (34.5) 28 (22.1)
Children in household (n = 287) None 138 (48.1) 89 (54.3) 49 (39.8)
⩽5 years 67 (23.3) 33 (20.1) 34 (27.6)
5–15 years 58 (20.2) 35 (21.3) 23 (18.7)
16 years and older 24 (8.4) 7 (4.3) 17 (13.8)
Socio-economic status (n = 297) Higher (poverty index*⩽ 3) 177 (59.6) 100 (58.5) 77 (61.1)
Lower (poverty index > 3) 120 (40.4) 71 (41.5) 49 (38.9)
Residence (n = 299) Urban 60 (20.1) 36 (20.9) 24 (18.9)
Rural 239 (79.9) 136 (79.1) 103 (81.1)
Social support (n = 298) Strong social support 56 (18.8) 31 (18.2) 25 (19.5)
Intermediate support 151 (50.7) 83 (48.8) 68 (53.1)
Poor support 91 (30.5) 56 (32.9) 35 (27.3)
Travel time to nearest health facility (n = 299) ⩽60 min 192 (64.2) 115 (67.3) 77 (60.2)
61–120 min 60 (20.1) 32 (18.7) 28 (21.9)
⩾121 min 47 (15.7) 24 (14.0) 23 (18.0)
Diagnosis Affective psychosis/bipolar disorder 44 (14.7) 21 (12.2) 23 (18.0)
Schizophrenia & other psychoses 256 (85.3) 151 (87.8) 105 (82.0)
Duration of illness (years) (n = 270) Median (interquartile range; IQR) 5 (2.8–10) 5 (2.8–10) 5.5 (2.8–11)
Onset of illness (n = 271) Acute/sub-acute 100 (36.9) 55 (35.5) 45 (38.8)
Gradual 171 (63.1) 100 (64.5) 71 (61.2)
Psychiatric admission In past 12 months 11 (3.7) 5 (2.9) 6 (4.7)
Treatment at recruitment (n = 261) Prescribed medication at baseline 69 (26.4) 35 (23.5) 34 (30.4)
Co-morbid medical disorder (n = 286) Diagnosed medical condition 18 (6.3) 13 (8.1) 5 (4.0)
*Poverty index = roof material made of straw (v. corrugated iron), unimproved water source, unimproved sanitation, no electricity, no separate room for kitchen, no radio or television, no
mobile phone.
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social outcomes of people with SMI was evaluated (Jordans et al.,
2017; Jordans et al., 2019). Both studies found a significant reduc-
tion in symptom severity, disability and caregiver burden but had
sample sizes under 100 and included extensive community-based
psychosocial interventions (Jordans et al., 2019). Our larger study,
which included a more representative population of people with
SMI and a task-sharing intervention more closely based on
mhGAP, provides more definitive evidence of important clinical
and social benefits from the recommended WHO mhGAP
approach.
In our study, the impact of the district mental health care plan
care on psychotic symptoms was less marked than the reductions
seen in the social outcomes, with a reduction of 4.8 on the BPRSE
being less than that usually considered to be clinically significant
(Hanlon et al., 2016a). In previous intervention studies for people
with SMI in LMIC settings, a key factor for clinical improvement
has been enhanced adherence to antipsychotic medication
(Chatterjee et al., 2014), but only 30% of people with SMI in
our study received ‘minimally adequate treatment’ over the
follow-up period. Our process data indicate that engagement
waxed and waned over time, rather than people dropping out of
care altogether, and lends support to the acceptability of care pro-
vided as well as providing explanation for the limited impact on
symptom improvement at cross-sectional assessment. In-depth
interviews with study participants with SMI who had disengaged
from care indicated that most had experienced symptomatic
improvement, but that affordability of medication and side effects
of medications was a barrier to continuous engagement. This is
supported by quantitative data from the same sample, indicating
high levels of poverty and out-of-pocket healthcare costs com-
pared to the general population (Hailemichael et al., 2019).
Mechanisms to reduce out-of-pocket healthcare costs for people
with SMI are needed to achieve improved access to mental health
care (Hanlon et al., 2019).
Although disability is closely linked to symptom severity, our
previous work in this community indicates that stigma, discrim-
ination and poverty also make important contributions. The bor-
derline significant effect modification indicating greater
improvements in disability in people with higher receipt of com-
munity support may reflect the impact of reduced social exclu-
sion. We observed a significant decline in perceived negative
discrimination in people with SMI. The PRIME mental health
care plan included a cascade model of training of community-
based health extension workers to raise community awareness
and reduce stigma against mental health problems (Fekadu
et al., 2016); however, the extent of implementation is not
known. The growing community and family awareness of the
treatability of SMI, arising from the local availability of a treat-
ment service and bearing witness to the clinical improvement of
people with SMI who were well-known to the community,
might have also reduced stigmatising attitudes, social exclusion
and the need for people to be restrained. Furthermore, the
Community Advisory Board members were selected due to
their level of community influence and their endorsement of
mental health care helped to reduce stigma and misconceptions
about mental illness in the study site. In a recent trial in
Table 2. Mixed-effects modelling of primary outcomes stratified by equity indicators
Outcome
Baseline (T0) Mean
(S.D.)
T0–T1 mean difference (95% confidence
intervals
T0–T2 mean difference (95% confidence
intervals
SMI symptoms (BPRS-E) N = 294 N = 247 N = 245
Total sample 48.5 (15.6) −2.6 (−4.8 to −0.4) −4.8 (−7.0 to −2.6)
Gender Male 47.9 (16.3) −2.2 (−5.2 to 0.9) −3.9 (−6.9 to −0.8)
Female 49.4 (14.7) −3.2 (−6.3 to −0.04) −6.0 (−9.1 to −2.8)
Residence Urban 47.4 (16.5) −4.0 (−9.3 to 1.2) −9.0 (−14.2 to −3.8)
Rural 48.9 (15.4) −2.3 (−4.7 to −0.1) −4.1 (−6.5 to −1.7)
Health care access <60 min 48.2 (16.2) −2.1 (−4.8 to −0.7) −5.5 (−8.3 to −2.8)
⩾60 min 49.3 (15.6) −3.9 (−7.5 to −0.3) −3.4 (−7.0 to 0.3)
Socio-economic
status
Higher 49.2 (16.0) −3.5 (−6.6 to −0.5) −5.6 (−8.6 to −2.5)
Lower 47.4 (15.1) −0.8 (−3.9 to 2.4) −3.1 (−6.2 to −0.02)
Disability (WHODAS 2.0) N = 296 N = 246 N = 245
Total sample 52.2 (22.0) −6.2 (−9.3 to −3.1) −12.0 (−15.1 to −8.9)
Gender Male 52.3 (21.5) −7.8 (−11.8 to −3.8) −10.1 (−14.2 to −6.0)
Female 52.1 (22.7) −4.2 (−9.0 to 0.6) −14.3, (−19.1 to −9.6)
Residence Urban 49.2 (22.3) −7.4 (−14.0 to −0.7) −14.1 (−20.6 to −7.5)
Rural 53.1 (21.9) −6.2 (−9.7 to −2.7) −11.8 (−15.3 to −8.2)
Health care access <60 min 50.4 (22.5) −4.8 (−8.7 to −0.8) −11.4 (−15.3 to −7.4)
⩾60 min 55.9 (20.7) −8.9 (−13.9 to −3.8) −13.4 (−18.5 to −8.3)
Socio-economic
status
Higher 50.0 (21.8) −6.9 (−11.1 to −2.7) −11.4 (−15.6 to −7.2)
Lower 55.3 (22.1) −4.7 (−9.3 to −0.1) −12.4 (−17.0 to −7.9)
The figures in bold are significant at p < 0.05.
Epidemiology and Psychiatric Sciences 7
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S2045796019000398
Downloaded from https://www.cambridge.org/core. University of Nottingham, on 13 Aug 2019 at 13:28:27, subject to the Cambridge Core terms of use, available at
Ghana, restraint was not reduced by short-term provision of
psychiatric care to people with SMI who were receiving faith heal-
ing in prayer camps (Ofori-Atta et al., 2018). In our study, the
follow-up period was longer, which may have allowed family
members and the community to gain confidence in the beneficial
effects of treatment and the PRIME intervention incorporated
community and system-level interventions as well as task-shared
facility-based care.
Alternative approaches to expanding access to care for people
with SMI in rural populations in LMICs have been reported. One
model is to utilise outreach clinics staffed by mental health specia-
lists who diagnose, prescribe and monitor clinical progress, com-
bined with community-level interventions by non-specialists to
promote social inclusion and functional recovery (Srinivasa
Murthy et al., 2005; Chatterjee et al., 2009; Chatterjee et al.,
2014). Another ‘back-referral’ model is for mental health specia-
lists to provide initial assessment and development of a care plan
which is then implemented by non-specialist health workers in
the local area combined with task-shared psychosocial interven-
tions (Xiang et al., 1994). Augmenting the PRIME model with
more intensive and systematic community-based rehabilitation
delivered by non-specialists may help to address some of the
gaps identified in our study by strengthening engagement with
PHC and supporting livelihoods (Asher et al., 2016), although
the affordability and sustainability of such approaches need
evaluation. There are no published reports of these task-sharing
service models being successfully, safely and sustainably taken
to scale and we have no evidence regarding their relative impact
on effective treatment coverage for people with SMI. In the future,
randomised controlled trials comparing task-shared models of
care for people with SMI are needed to inform policy decisions
(Hanlon et al., 2016a).
Limitations
PHC workers were informed of the research psychiatric nurse
diagnosis and changes in treatment plan. For diagnosis the con-
cordance was high and so this is unlikely to have affected the out-
come, but the treatment plan reflected task-shared care with
support from a mental health specialist. We only collected data
on the positive and not the negative predictive value of the
PHC worker diagnosis. Calculating the negative predictive value
would be an important focus for future studies. Due to ethical
concerns, there was no comparison group of people with SMI
receiving ‘usual care’, which would have amounted to no access
to evidence-based care for most people. However, outcomes in
people with untreated schizophrenia (who formed the majority
of our cohort) have been shown to be poor (Ran et al., 2001).
Given the chronicity and severity of SMI at baseline, spontaneous
improvement is unlikely. This is supported by the lack of an
Table 3. Secondary clinical and social outcomes in people with SMI stratified by gender
Outcome
Baseline (T0) Follow-up (T2) T0–T2 change
Mean (S.D.) Mean (S.D.) Mean difference
Depression symptoms (PHQ-9) N = 300 N = 245
Total sample 12.8 (5.43) 7.2 (4.80) −5.6 (−6.3 to −4.8)
Male 12.9 (5.64) 7.4 (4.84) −5.4 (−6.5 to −4.4)
Female 12.8 (5.15) 7.0 (4.75) −5.7 (−6.8 to −4.6)
Median (IQR) Median (IQR) Odds ratio
Discrimination (DISC-12) N = 300 N = 245
Total sample 2 (0–7) 0 (0–3) 0.4 (0.3–0.5)
Male 2 (0–7) 0 (0–4) 0.5 (0.3–0.8)
Female 3 (0–7) 0 (0–2) 0.2 (0.1–0.4)
N (%) N (%) Prevalence ratio
Alcohol use disorder (AUDIT⩾ 8) N = 300 N = 245
Total sample 87 (29.0) 40 (16.3) 0.6 (0.5–0.8)
Male 77 (44.8) 34 (25.2) 0.6 (0.4–0.8)
Female 10 (7.8) 6 (5.5) 0.7 (0.3–1.4)
Suicide attempts past 3 months N = 300 N = 245
Total sample 42 (14.0) 12 (4.9) 0.3 (0.2–0.6)
Male 20 (11.6) 8 (5.9) 0.5 (0.2–1.0)
Female 22 (17.2) 4 (3.6) 0.2 (0.1–0.5)
Restrained past 12 months N = 300 N = 245
Total sample 76 (25.3) 26 (10.6) 0.4 (0.3–0.6)
Male 52 (30.2) 13 (9.6) 0.3 (0.2–0.5)
Female 24 (18.8) 13 (11.8) 0.6 (0.3–1.0)
The figures in bold are significant at p < 0.05.
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association between baseline duration of illness or type of illness
onset and outcomes in our study.
Conclusions
An integrated district level mental health care plan employing a
task-sharing approach safely addressed the large treatment gap
for people with SMI in a rural, low-income country setting, result-
ing in improved clinical and social outcomes and reduced human
rights abuses. Training and supporting PHC workers to provide
mental health care has great potential as a sustainable and feasible
approach to the care of people with SMI in resource-poor settings.
Supplementary material. The supplementary material for this article can
be found at https://doi.org/10.1017/S2045796019000398.
Data. The datasets used and/or analysed during the current study are
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datasets will be made publicly available during 2019 (via www.prime.uct.ac.za).
Acknowledgements. We would like to express our thanks to the study par-
ticipants for generously giving their time and energy to complete interviews,
and to the field staff who worked tirelessly to ensure the smooth running of
the project.
Financial support. This study was funded by the UK Department for
International Development (DfID) [201446], as part of the Programme for
Improving Mental health care (PRIME). The views expressed in this article
do not necessarily reflect the UK Government’s official policies. CH is sup-
ported by the National Institute of Health Research (NIHR) Global Health
Research Unit on Health System Strengthening in Sub-Saharan Africa,
King’s College London (GHRU 16/136/54). The views expressed are those of
the author and not necessarily those of the NHS, the NIHR or the
Department of Health and Social Care. CH, CL, VP, AF and GM are supported
by PRIME. CH additionally receives support from AMARI as part of the
DELTAS Africa Initiative [DEL-15-01]. GT is supported by the National
Institute for Health Research (NIHR) Collaboration for Leadership in
Applied Health Research and Care South London at King’s College London
NHS Foundation Trust. The views expressed are those of the author(s) and
not necessarily those of the NHS, the NIHR or the Department of Health.
GT acknowledges financial support from the Department of Health via the
National Institute for Health Research (NIHR) Biomedical Research Centre
and Dementia Unit awarded to South London and Maudsley NHS
Foundation Trust in partnership with King’s College London and King’s
College Hospital NHS Foundation Trust. GT is supported by the European
Union Seventh Framework Programme (FP7/2007–2013) Emerald project.
GT also receives support from the National Institute of Mental Health of
the National Institutes of Health under award number R01MH100470
(Cobalt study). GT is also supported by the UK Medical Research Council
in relation to the Emilia (MR/S001255/1) and Indigo Partnership (MR/
R023697/1) awards. LA was supported by a Wellcome Trust Fellowship in
International Health [grant number 100142/Z/12/Z].
Conflict of interest. None.
Ethical standards. The authors assert that all procedures contributing to
this work comply with the ethical standards of the relevant national and insti-
tutional committees on human experimentation and with the Helsinki
Declaration of 1975, as revised in 2008.
References
American Psychiatric Association (1994) Diagnostic and Statistical Manual of
Mental Disorders (4th Edition) (DSM-IV). Washington, DC: APA.
Asher L, De Silva M, Hanlon C, Weiss HA, Birhane R, Ejigu DA, Medhin G,
Patel V and Fekadu A (2016) Community-based Rehabilitation Intervention
for people with Schizophrenia in Ethiopia (RISE): study protocol for a cluster
randomised controlled trial. Trials 17, 299.
Babor TF, Higgins-Biddle JC, Saunders JB and MG. M (2001) The Alcohol
use Disorders Identification Test: Guidelines for use in Primary Care, 2nd
Edn. Geneva: World Health Organizarion.
Baron EC, Rathod SD, Hanlon C, Prince M, Fedaku A, Kigozi F,
Jordans M, Luitel NP, Medhin G, Murhar V, Nakku J, Patel V,
Petersen I, Selohilwe O, Shidhaye R, Ssebunnya J, Tomlinson M,
Lund C and De Silva M (2018) Impact of district mental health care
plans on symptom severity and functioning of patients with priority mental
health conditions: the Programme for Improving Mental Health Care
(PRIME) cohort protocol. BMC Psychiatry 18, 61.
Borenstein M, Hedges LV, Higgins JPT and Rothstein HR (2009). Chapter 4:
Effect sizes based on means. In Introduction to Meta-Analysis. Chichester,
UK: John Wiley & Sons, Ltd, pp. 21–32.
Brohan E, Clement S, Rose D, Sartorius N and Thornicroft G (2013)
Development and psychometric evaluation of the Discrimination and
Stigma Scale (DISC). Psychiatry Research 208, 33–40.
Burlingame GM, Seaman S, Johnson JE, Whipple J, Richardson E, Rees F,
Earnshaw D, Spencer R, Payne M and O’Neil B (2006) Sensitivity to
change of the Brief Psychiatric Rating Scale – Extended (BPRS-E): an
item and subscale analysis. Psychological Services 3, 77–87.
Chatterjee S, Pillai A, Jain S, Cohen A and Patel V (2009) Outcomes of peo-
ple with psychotic disorders in a community-based rehabilitation pro-
gramme in rural India. British Journal of Psychiatry 195, 433–439.
Chatterjee S, Naik S, John S, Dabholkar H, Balaji M, Koschorke M,
Varghese M, Thara R, Weiss HA, Williams P, McCrone P, Patel V and
Thornicroft G (2014). Effectiveness of a community-based intervention
for people with schizophrenia and their caregivers in India (COPSI): a ran-
domised controlled trial. [Erratum appears in Lancet. 2014 Jun 14;383
(9934):2046]. Lancet 383, 1385–1394.
Dalgard OS, Dowrick C, Lehtinen V, Vazquez-Barquero JL, Casey P,
Wilkinson G, Ayuso-Mateos JL, Page H and Dunn G (2006) Negative
life events, social support and gender difference in depression: a multi-
national community survey with data from the ODIN study. Social
Psychiatry & Psychiatric Epidemiology 41, 444–451.
Fekadu A, Hanlon C, Thornicroft G, Lund C, Kaaya S, Alem A, Gureje O,
Cleare AJ, Patel V and Prince MJ (2015) Care for bipolar disorder in
LMICs needs evidence from local settings. The Lancet Psychiatry 2, 772–773.
Fekadu A, Hanlon C, Medhin G, Alem A, Selamu M, Giorgis T, Shibre T,
Teferra S, Tegegn T, Breuer E, Patel V, Tomlinson M, Thornicroft G,
Prince M and Lund C (2016) Development of a scalable mental healthcare
plan for a rural district in Ethiopia. British Journal of Psychiatry Supplement
208, s4–s12.
Gureje O, Abdulmalik J, Kola L, Musa E, Yasamy MT and Adebayo K
(2015) Integrating mental health into primary care in Nigeria: report of a
demonstration project using the mental health gap action programme inter-
vention guide. BMC Health Services Research 15, 242–242.
Habtamu K, Alem A, Medhin G, Fekadu A, Dewey M, Prince M and
Hanlon C (2017) Validation of the World Health Organization Disability
Assessment Schedule in people with severe mental disorders in rural
Ethiopia. Health and Quality of Life Outcomes 15, 64.
Habtamu K, Alem A, Medhin G, Fekadu A and Hanlon C (2018) Functional
impairment among people with severe and enduring mental disorder in
rural Ethiopia: a cross-sectional study. Social Psychiatry & Psychiatric
Epidemiology 53, 803–814. http://dx.doi.org/10.1007/s00127-00018-01546-
00126.
Hailemariam M, Fekadu A, Selamu M, Alem A, Medhin G, Wolde
Giorgis T, DeSilva M and Breuer E (2015) Developing a mental health
care plan in a low resource setting: the theory of change approach. BMC
Health Services Research 15, 429.
Hailemichael Y, Hailemariam D, Tirfessa K, Docrat S, Alem A, Medhin G,
Lund C, Chisholm D, Fekadu A and Hanlon C (2019) Catastrophic
out-of-pocket payments for households of peoplewith severemental disorder:
a comparative study in rural Ethiopia. International Journal of Mental Health
Systems 13, 39. https://doi.org/10.1186/s13033-13019-10294-13037.
Hanlon C, Luitel NP, Kathree T, Murhar V, Shrivasta S, Medhin G,
Ssebunnya J, Fekadu A, Shidhaye R, Petersen I, Jordans M, Kigozi F,
Thornicroft G, Patel V, Tomlinson M, Lund C, Breuer E, De Silva M
and Prince M (2014) Challenges and opportunities for implementing
Epidemiology and Psychiatric Sciences 9
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S2045796019000398
Downloaded from https://www.cambridge.org/core. University of Nottingham, on 13 Aug 2019 at 13:28:27, subject to the Cambridge Core terms of use, available at
integrated mental health care: a district level situation analysis from five
low- and middle-income countries. PLoS One 9, e88437.
Hanlon C, Medhin G, Selamu M, Breuer E, Worku B, Hailemariam M,
Lund C, Prince M and Fekadu A (2015) Validity of brief screening ques-
tionnaires to detect depression in primary care in Ethiopia. Journal of
Affective Disorders 186, 32–39.
Hanlon C, Alem A, Medhin G, Shibre T, Ejigu DA, Negussie H, Dewey M,
Wissow L, Prince M, Susser E, Lund C and Fekadu A (2016a) Task shar-
ing for the care of severe mental disorders in a low-income country
(TaSCS): study protocol for a randomised, controlled, non-inferiority
trial. Trials 17, 76.
Hanlon C, Fekadu A, Jordans M, Kigozi F, Peterson I, Shidhaye R,
Honikman S, Lund C, Prince M, Raja S, Thornicroft G, Tomlinson M
and Patel V (2016b) District Mental Health Care Plans for five low- and
middle-income countries: commonalities, variations and evidence gaps.
British Journal of Psychiatry Supplement 208, s47–s54.
Hanlon C, Alem A, Lund C, Hailemariam D, Assefa E, Giorgis TW and
Chisholm D (2019) Moving towards universal health coverage for mental
disorders in Ethiopia. International Journal of Mental Health Systems 13,
11. https://doi.org/10.1186/s13033-13019-10268-13039.
Jordans MJD, Aldridge L, Luitel NP, Baingana F and Kohrt BA (2017)
Evaluation of outcomes for psychosis and epilepsy treatment delivered by
primary health care workers in Nepal: a cohort study. International
Journal of Mental Health Systems 11, 70.
Jordans MJD, Luitel NP, Kohrt BA, Rathod SD, Garman EC, De Silva M,
Komproe IH, Patel V and Lund C (2019) Community-, facility-, and
individual-level outcomes of a district mental healthcare plan in a low-
resource setting in Nepal: a population-based evaluation. PLOS Medicine
16, e1002748.
Kroenke K and Spitzer RL (2002) The PHQ-9: a new depression diagnostic
and severity measure. Psychiatric Annals 32, 509–515.
Lauritsen JM and Bruus M (2003). Epidata (Version 3). A comprehensive
tool for validated entry and documentation of data. The Epidata
Association: Odense, Denmark.
McGuffin P, Farmer AE and Harvey I (1991) A polydiagnostic application
of operational criteria in studies of psychotic illness: development and
reliability of the OPCRIT system. Archives of General Psychiatry 48,
764–770.
Ofori-Atta A, Attafuah J, Jack H, Baning F and Rosenheck R (2018) Joining
psychiatric care and faith healing in a prayer camp in Ghana: randomised
trial. The British Journal of Psychiatry 212, 34–41.
Ran MS, Xiang MZ, Huang MS and Shan YH (2001) Natural course of
schizophrenia: 2-year follow-up study in a rural Chinese community.
British Journal of Psychiatry 178, 154–158.
Sheehan DV, Lecrubier Y, Harnett-Sheehan K, Janavs J, Weiller E,
Bonara LI, Keskiner A, Schinka J, Knapp E, Sheehan MF and
Dunbar GC (1997) Reliability and validity of the MINI International
Neuropsychiatric Interview (M.I.N.I.): according to the SCID-P. European
Psychiatry 12, 232–241.
Shibre T, Kebede D, Alem A, Negash A, Kibreab S, Fekadu A, Fekadu D,
Jacobsson L and Kullgren G (2002) An evaluation of two screening meth-
ods to identify cases with schizophrenia and affective disorders in a com-
munity survey in rural Ethiopia. International Journal of Social Psychiatry
48, 200–208.
Srinivasa Murthy R, Kishore Kumar KV, Chisholm D, Thomas T, Sekar K
and Chandrashekar CR (2005) Community outreach for untreated schizo-
phrenia in rural India: a follow-up study of symptoms, disability, family
burden and costs. Psychological Medicine 35, 341–351.
StataCorp LP (2016) Stata version 13.1. Texas, USA.
Üstün TB, Chatterji S, Kostanjsek N, Rehm J, Kennedy C, Epping-Jordan J,
Saxena S, von Korffe M, Pullf C and in collaboration with WHO/NIH
Joint Project (2010) Developing the world health organization disability
assessment schedule 2.0. Bulletin of the World Health Organization 88,
815–823.
Ventevogel P, van de Put W, Faiz H, van Mierlo B, Siddiqi M and
Komproe IH (2012) Improving access to mental health care and psycho-
social support within a Fragile context: a case study from Afghanistan.
PLOS Medicine 9, e1001225.
Wang PS, Demler O and Kessler RC (2002) Adequacy of treatment for ser-
ious mental illness in the United States. American Journal of Public Health
92, 92–98.
Wang PS, Angermeyer M, Borges G, Bruffaerts R, Chiu WT, de
Girolamo G, Fayyad J, Gureje O, Haro JM, Huang Y, Kessler RC,
Kovess V, Levinson D, Nakane Y, Brown MAO, Ormel JH,
Posada-Villa J, Aguilar-Gaxiola S, Alonso J, Lee S, Heering S,
Pennell B-E, Chatterji S, Ustun TB and for the WHO World Mental
Health Survey Consortium (2007) Delay and failure in treatment seeking
after first onset of mental health disorders in the world health organization’s
world mental health survey initiative. World Psychiatry 6, 177–185.
World Health Organization (2008) Mental Health Gap Action Programme
(mhGAP): Scaling up Care for Mental, Neurological, and Substance use
Disorders. Geneva: WHO.
World Health Organization (2016) Mental Health Gap Action Programme
Intervention Guide (mhGAP-IG) for Mental, Neurological and Substance
use Disorders in non-Specialized Health Settings, Version 2.0. Geneva: WHO.
Xiang M, Ran M and Li S (1994) A controlled evaluation of psychoeduca-
tional family intervention in a rural Chinese community. British Journal
of Psychiatry 154, 544–548.
10 C. Hanlon et al.
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S2045796019000398
Downloaded from https://www.cambridge.org/core. University of Nottingham, on 13 Aug 2019 at 13:28:27, subject to the Cambridge Core terms of use, available at
